{
    "info": {
        "nct_id": "NCT05430035",
        "official_title": "Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder Adenocarcinoma",
        "inclusion_criteria": "* Subjects must have histologically or cytologically confirmed gallbladder adenocarcinoma AND inadvertent spillage of bile or intentional decompression during cholecystectomy OR tumors extending through the serosa of the gallbladder (T3/T4) OR poorly differentiated gallbladder adenocarcinoma.\n* ECOG Performance status ≤ 2\n* Subjects must have normal organ and marrow function as defined below:\n\n  * Hemoglobin ≥ 10.0 g/dl\n  * Leukocytes ≥ 3,000/mcL\n  * Absolute neutrophil count ≥ 1,500/mcL\n  * Platelet count ≥ 100,000/mcL\n  * Total bilirubin within normal institutional limits\n  * AST (SGOT) ≤ 2.5 X institutional upper limit of normal\n  * ALT (SGPT) ≤ 2.5 X institutional upper limit of normal\n  * Serum Creatinine within normal institutional limits\n* Eligible TNM staging includes >T1b meeting above criteria, any N, and M0\n* Eligible candidates for standard surgical management which includes central liver resection (+ cholecystectomy if not already performed) and portal lymphadenectomy\n* Subjects must have the ability to understand and the willingness to sign a written informed consent document\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Prior systemic therapy for gallbladder adenocarcinoma\n* Subjects receiving any other investigational agents.\n* Subjects with known or suspected metastatic disease\n* History of allergic reactions attributed to compounds of similar chemical or biologic composition to MMC or other agents used in this study.\n* Subjects with uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.\n* Pregnant or breastfeeding are excluded from this study because MMC has the potential for teratogenic or abortifacient effects. Because there is known risk for adverse events in nursing infants secondary to treatment of the mother with MMC, breastfeeding should be discontinued if the mother is treated with MMC.\n* Subjects with past medical history of hepatitis B or C\n* Subjects with evidence of biliary obstruction thought to be cancer related, including subjects requiring biliary stent",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Hemoglobin ≥ 10.0 g/dl",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin ≥ 10.0 g/dl",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10.0,
                                "unit": "g/dl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelet count ≥ 100,000/mcL",
            "criterions": [
                {
                    "exact_snippets": "Platelet count ≥ 100,000/mcL",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "mcL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Total bilirubin within normal institutional limits",
            "criterions": [
                {
                    "exact_snippets": "Total bilirubin within normal institutional limits",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "range",
                            "expected_value": "within normal institutional limits"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Absolute neutrophil count ≥ 1,500/mcL",
            "criterions": [
                {
                    "exact_snippets": "Absolute neutrophil count ≥ 1,500/mcL",
                    "criterion": "absolute neutrophil count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1500,
                                "unit": "mcL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects must have normal organ and marrow function as defined below:",
            "criterions": [
                {
                    "exact_snippets": "normal organ and marrow function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "functionality",
                            "expected_value": "normal"
                        }
                    ]
                },
                {
                    "exact_snippets": "normal organ and marrow function",
                    "criterion": "marrow function",
                    "requirements": [
                        {
                            "requirement_type": "functionality",
                            "expected_value": "normal"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* AST (SGOT) ≤ 2.5 X institutional upper limit of normal",
            "criterions": [
                {
                    "exact_snippets": "AST (SGOT) ≤ 2.5 X institutional upper limit of normal",
                    "criterion": "AST (SGOT) level",
                    "requirements": [
                        {
                            "requirement_type": "comparison",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "X institutional upper limit of normal"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteers",
                    "requirements": [
                        {
                            "requirement_type": "allowed",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum Creatinine within normal institutional limits",
            "criterions": [
                {
                    "exact_snippets": "Serum Creatinine within normal institutional limits",
                    "criterion": "Serum Creatinine",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": "within normal institutional limits"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG Performance status ≤ 2",
            "criterions": [
                {
                    "exact_snippets": "ECOG Performance status ≤ 2",
                    "criterion": "ECOG Performance status",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects must have the ability to understand and the willingness to sign a written informed consent document",
            "criterions": [
                {
                    "exact_snippets": "ability to understand",
                    "criterion": "cognitive ability",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness to sign a written informed consent document",
                    "criterion": "willingness to consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Leukocytes ≥ 3,000/mcL",
            "criterions": [
                {
                    "exact_snippets": "Leukocytes ≥ 3,000/mcL",
                    "criterion": "leukocytes",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3000,
                                "unit": "mcL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ALT (SGPT) ≤ 2.5 X institutional upper limit of normal",
            "criterions": [
                {
                    "exact_snippets": "ALT (SGPT) ≤ 2.5 X institutional upper limit of normal",
                    "criterion": "ALT (SGPT) level",
                    "requirements": [
                        {
                            "requirement_type": "comparison",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "X institutional upper limit of normal"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eligible TNM staging includes >T1b meeting above criteria, any N, and M0",
            "criterions": [
                {
                    "exact_snippets": "Eligible TNM staging includes >T1b",
                    "criterion": "TNM staging",
                    "requirements": [
                        {
                            "requirement_type": "T stage",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "b"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Eligible TNM staging includes ... any N",
                    "criterion": "TNM staging",
                    "requirements": [
                        {
                            "requirement_type": "N stage",
                            "expected_value": "any"
                        }
                    ]
                },
                {
                    "exact_snippets": "Eligible TNM staging includes ... M0",
                    "criterion": "TNM staging",
                    "requirements": [
                        {
                            "requirement_type": "M stage",
                            "expected_value": "0"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eligible candidates for standard surgical management which includes central liver resection (+ cholecystectomy if not already performed) and portal lymphadenectomy",
            "criterions": [
                {
                    "exact_snippets": "Eligible candidates for standard surgical management",
                    "criterion": "eligibility for standard surgical management",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "central liver resection",
                    "criterion": "central liver resection",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "cholecystectomy if not already performed",
                    "criterion": "cholecystectomy",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "portal lymphadenectomy",
                    "criterion": "portal lymphadenectomy",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects must have histologically or cytologically confirmed gallbladder adenocarcinoma AND inadvertent spillage of bile or intentional decompression during cholecystectomy OR tumors extending through the serosa of the gallbladder (T3/T4) OR poorly differentiated gallbladder adenocarcinoma.",
            "criterions": [
                {
                    "exact_snippets": "histologically or cytologically confirmed gallbladder adenocarcinoma",
                    "criterion": "gallbladder adenocarcinoma",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": [
                                "histologically",
                                "cytologically"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "inadvertent spillage of bile",
                    "criterion": "spillage of bile",
                    "requirements": [
                        {
                            "requirement_type": "inadvertent",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "intentional decompression during cholecystectomy",
                    "criterion": "decompression during cholecystectomy",
                    "requirements": [
                        {
                            "requirement_type": "intentional",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "tumors extending through the serosa of the gallbladder (T3/T4)",
                    "criterion": "tumor extension",
                    "requirements": [
                        {
                            "requirement_type": "location",
                            "expected_value": "through the serosa of the gallbladder"
                        },
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "T3",
                                "T4"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "poorly differentiated gallbladder adenocarcinoma",
                    "criterion": "gallbladder adenocarcinoma differentiation",
                    "requirements": [
                        {
                            "requirement_type": "differentiation",
                            "expected_value": "poorly differentiated"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Prior systemic therapy for gallbladder adenocarcinoma",
            "criterions": [
                {
                    "exact_snippets": "Prior systemic therapy for gallbladder adenocarcinoma",
                    "criterion": "prior systemic therapy",
                    "requirements": [
                        {
                            "requirement_type": "condition",
                            "expected_value": "gallbladder adenocarcinoma"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with known or suspected metastatic disease",
            "criterions": [
                {
                    "exact_snippets": "known or suspected metastatic disease",
                    "criterion": "metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": [
                                "known",
                                "suspected"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of allergic reactions attributed to compounds of similar chemical or biologic composition to MMC or other agents used in this study.",
            "criterions": [
                {
                    "exact_snippets": "History of allergic reactions attributed to compounds of similar chemical or biologic composition to MMC",
                    "criterion": "allergic reactions to MMC or similar compounds",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of allergic reactions attributed to ... other agents used in this study",
                    "criterion": "allergic reactions to other agents used in this study",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnant or breastfeeding are excluded from this study because MMC has the potential for teratogenic or abortifacient effects. Because there is known risk for adverse events in nursing infants secondary to treatment of the mother with MMC, breastfeeding should be discontinued if the mother is treated with MMC.",
            "criterions": [
                {
                    "exact_snippets": "Pregnant ... are excluded from this study",
                    "criterion": "pregnancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding are excluded from this study",
                    "criterion": "breastfeeding",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects receiving any other investigational agents.",
            "criterions": [
                {
                    "exact_snippets": "Subjects receiving any other investigational agents.",
                    "criterion": "investigational agents",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with past medical history of hepatitis B or C",
            "criterions": [
                {
                    "exact_snippets": "past medical history of hepatitis B",
                    "criterion": "hepatitis B",
                    "requirements": [
                        {
                            "requirement_type": "past medical history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "past medical history of ... C",
                    "criterion": "hepatitis C",
                    "requirements": [
                        {
                            "requirement_type": "past medical history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with evidence of biliary obstruction thought to be cancer related, including subjects requiring biliary stent",
            "criterions": [
                {
                    "exact_snippets": "evidence of biliary obstruction thought to be cancer related",
                    "criterion": "biliary obstruction",
                    "requirements": [
                        {
                            "requirement_type": "cause",
                            "expected_value": "cancer related"
                        }
                    ]
                },
                {
                    "exact_snippets": "requiring biliary stent",
                    "criterion": "biliary stent",
                    "requirements": [
                        {
                            "requirement_type": "necessity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.",
            "criterions": [
                {
                    "exact_snippets": "uncontrolled intercurrent illness",
                    "criterion": "intercurrent illness",
                    "requirements": [
                        {
                            "requirement_type": "control",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "ongoing or active infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "ongoing or active"
                        }
                    ]
                },
                {
                    "exact_snippets": "symptomatic congestive heart failure",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "symptoms",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "unstable angina pectoris",
                    "criterion": "angina pectoris",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "cardiac arrhythmia",
                    "criterion": "cardiac arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "psychiatric illness/social situations that would limit compliance with study requirements",
                    "criterion": "psychiatric illness/social situations",
                    "requirements": [
                        {
                            "requirement_type": "impact on compliance",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}